Backtracking cryptic recurrence of esophageal cancer from membranous nephropathy: the detection of glomerular NELL-1 and IgG4

Author:

Zhou Shuai12,Meng FuLei2,Yue ShuLing3,Li Hang4,Zhang LiHong2,Wang Tao2

Affiliation:

1. HeBei Medical University, Graduate School , ShiJiaZhuang , China

2. The First Hospital of HeBei Medical University, Department of Nephrology , ShiJiaZhuang , China

3. Guangzhou KingMed Center for Clinical Laboratory , GuangZhou , China

4. BeiJing Union Medical College, Department of Nephrology , BeiJing , China

Abstract

ABSTRACT We reported the detection of neural epidermal growth factor-like 1 (NELL-1) and immunoglobulin G4 (IgG4) on glomerular capillary wall in membrane nephropathy (MN), which led to the discovery of early post-operative recurrence of esophageal squamous cell cancer (ESCC) in a 68-year-old man. Further, NELL-1 was also identified in the cancerous tissue sampled by esophagoscope. Moreover, serum IgG4 percentage seemed to be higher when comparing with both previous reports and another age-matched male with NELL-1-negative MN upon fully recovered ESCC. Therefore, the finding of NELL-1 in a renal biopsy should trigger a detailed workup in search of malignancy, especially with concomitant IgG4 dominance.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Reference15 articles.

1. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy;Sethi;Kidney Int,2020

2. Antigens, antibodies, and membranous nephropathy: a decade of progress;Ahmad;Kidney Int,2020

3. Membranous nephropathy: core curriculum 2021;Alsharhan;Am J Kidney Dis,2021

4. Advances in membranous nephropathy;Ronco;J Clin Med,2021

5. NELL1 is a target antigen in malignancy-associated membranous nephropathy;Caza;Kidney Int,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3